Latanoprost/Timolol Teva

Latanoprost/Timolol, the active ingredient in Latanoprost/Timolol Teva, is a prostaglandin analog / beta‑blocker combination presented as an ophthalmic solution for ocular use. It treats open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost/Timolol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol is indicated for conditions affecting intraocular pressure within the glaucoma and ocular hypertension disease family.

- Open‑angle glaucoma: lowers intraocular pressure to slow disease progression. - Ocular hypertension: reduces elevated eye pressure to lower risk of developing glaucoma. - Secondary open‑angle glaucoma: assists in controlling pressure when caused by other ocular conditions.

Adverse reactions to Latanoprost/Timolol may involve the ocular surface, peri‑ocular tissues, or systemic systems.

Common Side Effects: - Eye irritation: mild burning or stinging after instillation. - Blurred vision: temporary focus changes following dosing. - Eye redness: conjunctival hyperemia. - Increased iris pigmentation: gradual darkening of the iris. - Eyelash growth: longer, thicker lashes. - Dry eye: reduced tear film stability.

Serious or Rare Side Effects: - Severe allergic reaction: angioedema or anaphylaxis requiring immediate medical attention. - Bronchospasm: respiratory difficulty in susceptible patients. - Bradycardia or hypotension: marked slowing of heart rate or low blood pressure. - Persistent eye pain: may indicate corneal involvement. - Corneal ulcer or keratitis: ulcerative lesions requiring urgent care. - Uveitis: intraocular inflammation that can threaten vision.

Before using Latanoprost/Timolol, consider the following precautions.

- Pregnancy: safety not established; use only if potential benefit justifies the risk. - Breastfeeding: unknown excretion; weigh maternal benefit against possible infant exposure. - Respiratory disease: avoid in patients with asthma or COPD due to beta‑blocker effects. - Cardiovascular disease: monitor for bradycardia, hypotension, or heart block. - Contact lens wearers: may cause discoloration; advise removal before instillation. - Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost/Timolol may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: additive bradycardia or hypotension. - Sympathomimetic agents (e.g., epinephrine eye drops): may diminish ocular hypotensive effect. - MAO inhibitors combined with topical sympathomimetics: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely):\n- Oral carbonic anhydrase inhibitors: additive intraocular pressure reduction. - Systemic corticosteroids: may lessen prostaglandin efficacy. - Other ocular hypotensives (e.g., brimonidine): monitor IOP for over‑reduction.